FDA Intensifies Crackdown on GLP-1 Compounding
(MedPage Today) -- The FDA is proposing the removal of three GLP-1 drugs from the 503B bulks list of active ...
Tag: FDA
FDA Analysis Says Infant Formula Supply Is Safe After Testing for Contaminants
(MedPage Today) -- A new analysis of chemicals in U.S. infant formula found reassuringly low levels of heavy metals, pesticides, ...
Find Alternative to Glucometer Linked With 114 Injuries, FDA Says
(MedPage Today) -- Patients using recalled True Metrix blood glucose monitoring systems linked to one death and over 100 serious ...
Electric Shock Ban? FDA Expands Caplyta Label; Bipolar Disorder Strategies
(MedPage Today) -- The FDA may decide soon whether to ban using electric shocks on people with disabilities, including children ...
3 Deaths Tied to Medical Device; FDA Eyes Shock Ban; RFK Jr.’s Vaccine Aid Freeze
(MedPage Today) -- Note that some links may require registration or subscription. The FDA warned of three deaths associated with ...
FDA Says First ‘Real-Time’ Clinical Trial Is Underway
(MedPage Today) -- The FDA announced the launch of the first "real-time" clinical trial, with a second soon following, that ...
FDA Claims ‘Manipulated’ Data Led to Drug’s Approval, Proposes Withdrawal
(MedPage Today) -- The FDA said that "manipulated" data supported the approval of avacopan (Tavneos) for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated ...
FDA proposes to withdraw Amgen’s drug for rare autoimmune diseases over effectiveness
The FDA advised healthcare professionals to discuss Tavneos and alternative treatment options with patients while a final decision on the ...
FDA Plans Ultra-Fast Review of Three Psychedelics for Depression, PTSD
(MedPage Today) -- The FDA said Friday it will offer ultra-fast review to three psychedelic drugs being developed for hard-to-treat ...
FDA Expands Approval of Drug to Stave Off Type 1 Diabetes
(MedPage Today) -- The FDA expanded the approval for teplizumab (Tzield), a biologic that delays the progression of preclinical type ...